Insider Transactions in Q3 2024 at Rhythm Pharmaceuticals, Inc. (RYTM)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2024
|
Jennifer L Good Director |
SELL
Open market or private sale
|
Direct |
31,751
-91.37%
|
$1,651,052
$52.4 P/Share
|
|
Sep 17
2024
|
Jennifer L Good Director |
BUY
Exercise of conversion of derivative security
|
Direct |
31,751
+29.52%
|
$666,771
$21.1 P/Share
|
|
Sep 10
2024
|
Lynn A. Tetrault Director |
SELL
Open market or private sale
|
Direct |
17,501
-41.32%
|
$857,549
$49.95 P/Share
|
|
Sep 10
2024
|
Lynn A. Tetrault Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,501
+35.13%
|
$192,511
$11.57 P/Share
|
|
Sep 09
2024
|
Jennifer L Good Director |
SELL
Open market or private sale
|
Direct |
37,241
-92.54%
|
$1,862,050
$50.45 P/Share
|
|
Sep 09
2024
|
Jennifer L Good Director |
BUY
Exercise of conversion of derivative security
|
Direct |
37,241
+25.24%
|
$595,856
$16.86 P/Share
|
|
Sep 09
2024
|
Lynn A. Tetrault Director |
SELL
Open market or private sale
|
Direct |
3,199
-51.61%
|
$159,950
$50.04 P/Share
|
|
Sep 09
2024
|
Lynn A. Tetrault Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,199
+34.04%
|
$57,582
$18.99 P/Share
|
|
Sep 09
2024
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,099
-23.29%
|
$204,950
$50.03 P/Share
|
|
Sep 09
2024
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,099
+18.89%
|
$77,881
$19.02 P/Share
|
|
Aug 26
2024
|
Jennifer L Good Director |
SELL
Open market or private sale
|
Direct |
14,508
-82.87%
|
$725,400
$50.01 P/Share
|
|
Aug 26
2024
|
Jennifer L Good Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,508
+24.43%
|
$232,128
$16.86 P/Share
|
|
Aug 26
2024
|
Lynn A. Tetrault Director |
SELL
Open market or private sale
|
Direct |
4,300
-58.9%
|
$215,000
$50.01 P/Share
|
|
Aug 26
2024
|
Lynn A. Tetrault Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,300
+37.07%
|
$77,400
$18.99 P/Share
|
|
Aug 26
2024
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
3,200
-19.16%
|
$160,000
$50.01 P/Share
|
|
Aug 26
2024
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,200
+16.08%
|
$60,800
$19.02 P/Share
|
|
Aug 12
2024
|
Lynn A. Tetrault Director |
SELL
Open market or private sale
|
Direct |
10,000
-42.87%
|
$440,000
$44.99 P/Share
|
|
Aug 12
2024
|
Lynn A. Tetrault Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.48%
|
$40,000
$4.15 P/Share
|
|
Aug 09
2024
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
49,006
-44.26%
|
$2,205,270
$45.38 P/Share
|
|
Aug 09
2024
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,771
+32.99%
|
$584,649
$19.02 P/Share
|
|
Jul 29
2024
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,395
-4.21%
|
$68,355
$49.06 P/Share
|
|
Jul 26
2024
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+8.62%
|
-
|
|
Jul 16
2024
|
Joseph Shulman Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
10,468
-99.71%
|
$554,804
$53.0 P/Share
|
|
Jul 16
2024
|
Joseph Shulman Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,468
+49.93%
|
$282,636
$27.35 P/Share
|
|
Jul 12
2024
|
Joseph Shulman Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
5,313
-99.44%
|
$265,650
$50.01 P/Share
|
|
Jul 12
2024
|
Joseph Shulman Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,313
+49.86%
|
$111,573
$21.38 P/Share
|